Home > Drug Search >
  • company_query: BioNet-Asia
  •   > 
Drug Filter
Category:
chemistry (3) biology (34)
Status:
Approved (1) NDA Filing (1) BLA Filing (1) Phase Ⅲ (7) Phase Ⅱ (18) Phase Ⅰ (9)
Clinical Stage:
Pending (2) Active (29) Discontinued (5)
Bio-Type:
Gene therapy (1) Cell therapy (2) CAR T cell therapy (3) Vaccine (19) Animal extract (1) Bispecific antibody (1) Whole antibody (3)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Deep vein thrombosis (DVT) (1) Gynaecological disorders (1) Blastic plasmacytoid dendritic cell neoplasm (1) HIV infection (1) Influenza virus infection (1) Rabies (1) Pseudomonal infection (1) Melanoma (1) Multiple myeloma (MM) (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (2) Pneumonia (1) HEV infection (1) Diphtheria (1) Pertussis (2) Prostate cancer (2) Poliomyelitis (1) Tetanus (1) Exocrine pancreatic insufficiency (1) Solid tumours (2) Rotavirus infection (1) Tuberculosis (1) Venous thromboembolism (VTE) (1) Cervical intraepithelial neoplasia (1) Colorectal cancer (1) Unstable angina (1) Bipolar disorder (1) Cervical carcinoma (1) Malaria (2) Staphylococcal infection (1) Glioblastoma (1) Glioma (1) Clostridial infection (1) Plaque psoriasis (1) High-grade cervical intraepithelial neoplasia (2) Inflammation (1) Human papillomavirus infections (HPV) (1) Immunological disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top